177 related articles for article (PubMed ID: 33135940)
1. Neurokinin 3 receptor antagonists - prime time?
Prague JK
Climacteric; 2021 Feb; 24(1):25-31. PubMed ID: 33135940
[TBL] [Abstract][Full Text] [Related]
2. Neurokinin 3 receptor antagonism - the magic bullet for hot flushes?
Prague JK; Dhillo WS
Climacteric; 2017 Dec; 20(6):505-509. PubMed ID: 29040006
[TBL] [Abstract][Full Text] [Related]
3. Neurokinin 3 Receptor Antagonism: A Novel Treatment for Menopausal Hot Flushes.
Modi M; Dhillo WS
Neuroendocrinology; 2019; 109(3):242-248. PubMed ID: 30504731
[TBL] [Abstract][Full Text] [Related]
4. The neurokinin B pathway in the treatment of menopausal hot flushes.
Anderson RA; Skorupskaite K; Sassarini J
Climacteric; 2019 Feb; 22(1):51-54. PubMed ID: 30572747
[TBL] [Abstract][Full Text] [Related]
5. Neurokinin 3 receptor antagonism as a novel treatment for menopausal hot flushes: a phase 2, randomised, double-blind, placebo-controlled trial.
Prague JK; Roberts RE; Comninos AN; Clarke S; Jayasena CN; Nash Z; Doyle C; Papadopoulou DA; Bloom SR; Mohideen P; Panay N; Hunter MS; Veldhuis JD; Webber LC; Huson L; Dhillo WS
Lancet; 2017 May; 389(10081):1809-1820. PubMed ID: 28385352
[TBL] [Abstract][Full Text] [Related]
6. Neurokinin B and Neurokinin-3 Receptor Signaling: Promising Developments in the Management of Menopausal Hot Flushes.
Modi M; Dhillo WS
Semin Reprod Med; 2019 May; 37(3):125-130. PubMed ID: 31869840
[TBL] [Abstract][Full Text] [Related]
7. Neurokinin 3 Receptor Antagonists Compared With Serotonin Norepinephrine Reuptake Inhibitors for Non-Hormonal Treatment of Menopausal Hot Flushes: A Systematic Qualitative Review.
Menown SJ; Tello JA
Adv Ther; 2021 Oct; 38(10):5025-5045. PubMed ID: 34514552
[TBL] [Abstract][Full Text] [Related]
8. Neurokinin 3 Receptor Antagonism Reveals Roles for Neurokinin B in the Regulation of Gonadotropin Secretion and Hot Flashes in Postmenopausal Women.
Skorupskaite K; George JT; Veldhuis JD; Millar RP; Anderson RA
Neuroendocrinology; 2018; 106(2):148-157. PubMed ID: 28380486
[TBL] [Abstract][Full Text] [Related]
9. Menopause review: Emerging treatments for menopausal symptoms.
Patel B; S Dhillo W
Best Pract Res Clin Obstet Gynaecol; 2022 May; 81():134-144. PubMed ID: 34965909
[TBL] [Abstract][Full Text] [Related]
10. Phytoestrogens for menopausal vasomotor symptoms.
Lethaby A; Marjoribanks J; Kronenberg F; Roberts H; Eden J; Brown J
Cochrane Database Syst Rev; 2013 Dec; 2013(12):CD001395. PubMed ID: 24323914
[TBL] [Abstract][Full Text] [Related]
11. Bioidentical hormones for women with vasomotor symptoms.
Gaudard AM; Silva de Souza S; Puga ME; Marjoribanks J; da Silva EM; Torloni MR
Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD010407. PubMed ID: 27479272
[TBL] [Abstract][Full Text] [Related]
12. Fezolinetant in the treatment of vasomotor symptoms associated with menopause.
Depypere H; Lademacher C; Siddiqui E; Fraser GL
Expert Opin Investig Drugs; 2021 Jul; 30(7):681-694. PubMed ID: 33724119
[No Abstract] [Full Text] [Related]
13. Effects of neurokinin 3 receptor antagonist fezolinetant on hot flash-like symptoms in ovariectomized rats.
Tahara A; Takamatsu H; Ohtake A; Tanaka-Amino K; Kaku S
Eur J Pharmacol; 2021 Aug; 905():174207. PubMed ID: 34048742
[TBL] [Abstract][Full Text] [Related]
14. Menopausal hot flushes and night sweats: where are we now?
Archer DF; Sturdee DW; Baber R; de Villiers TJ; Pines A; Freedman RR; Gompel A; Hickey M; Hunter MS; Lobo RA; Lumsden MA; MacLennan AH; Maki P; Palacios S; Shah D; Villaseca P; Warren M
Climacteric; 2011 Oct; 14(5):515-28. PubMed ID: 21848495
[TBL] [Abstract][Full Text] [Related]
15. Managing vasomotor symptoms in women after cancer.
Pinkerton JV; Santen RJ
Climacteric; 2019 Dec; 22(6):544-552. PubMed ID: 31081391
[TBL] [Abstract][Full Text] [Related]
16. Psychosocial and socioeconomic burden of vasomotor symptoms in menopause: a comprehensive review.
Utian WH
Health Qual Life Outcomes; 2005 Aug; 3():47. PubMed ID: 16083502
[TBL] [Abstract][Full Text] [Related]
17. New advances in menopause symptom management.
Koysombat K; McGown P; Nyunt S; Abbara A; Dhillo WS
Best Pract Res Clin Endocrinol Metab; 2024 Jan; 38(1):101774. PubMed ID: 37076317
[TBL] [Abstract][Full Text] [Related]
18. Treatment of Menopausal Vasomotor Symptoms With Fezolinetant, a Neurokinin 3 Receptor Antagonist: A Phase 2a Trial.
Depypere H; Timmerman D; Donders G; Sieprath P; Ramael S; Combalbert J; Hoveyda HR; Fraser GL
J Clin Endocrinol Metab; 2019 Dec; 104(12):5893-5905. PubMed ID: 31415087
[TBL] [Abstract][Full Text] [Related]
19. Black cohosh (Cimicifuga spp.) for menopausal symptoms.
Leach MJ; Moore V
Cochrane Database Syst Rev; 2012 Sep; 2012(9):CD007244. PubMed ID: 22972105
[TBL] [Abstract][Full Text] [Related]
20. Oral oestrogen and combined oestrogen/progestogen therapy versus placebo for hot flushes.
Maclennan AH; Broadbent JL; Lester S; Moore V
Cochrane Database Syst Rev; 2004 Oct; 2004(4):CD002978. PubMed ID: 15495039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
